XII Medical

About XII Medical

XII Medical is focused on transforming neuromodulation for obstructive sleep apnea by developing best-in-class therapies to simplify treatment, expand access, and improve outcomes.

Products & Services

Neuromodulation Therapy:A best-in-class therapy designed for obstructive sleep apnea to simplify treatment and improve outcomes.

Specialties

Neuromodulation Obstructive Sleep Apnea Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 45000000 MR: - FA: $45 million FAN: 45000000	D: 2024-08-21 FD: 2024-08-21	8 investors

Series B Latest

2024-08-21

$45.0M

8 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

XII Medical Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised